[BGLC] YoY Quarter Result on 30-Jun-2018 [#Q2]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
29-Jun-2018
Financial Year
2018
Quarter
30-Jun-2018 [#Q2]
Profit Trend
QoQ- -114.34%
YoY-
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 1,975 2,567 2,485 3,092 7 22 111 61.50%
PBT 255 -275 -140 137 -66 -69 -39 -
Tax 56 -16 -2 108 0 1 0 -
NP 199 -259 -139 28 -67 -70 -39 -
Tax Rate -21.82% - - -79.30% - - - -
Total Cost 1,775 2,826 2,624 3,064 73 92 151 50.73%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 10.08 -10.10 -5.58 0.91 -1,017.23 -325.24 -35.47 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS 0.01 -0.02 -0.01 0.00 -0.01 -0.01 -0.01 -
EPS Diluted 0.01 -0.02 -0.01 0.00 -0.01 -0.01 -0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.